MOZ: double bogey.
Mozz response is faulty on at least two points.
Point 1: PAR is no longer “fast track”. The slow postponed FDA response clearly demonstrates this. NOT GOOD NEWS.
Point 2: Claims of magnificent PAR generated data are not supported by any publications in leading OA journals. NOTHING but promises- promises- promises. MaRVeL oral PPS publication in British Medical Journal – open, a peer reviewed article. Is PAR data package amateur flawed and non-compliant. NOT GOOD NEWS.
https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12621000654853
https://bmjopen.bmj.com/content/bmjopen/14/5/e083046.full.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985017/
https://www.sydney.edu.au/medicine-health/about/our-people/academic-staff/david.hunter.html
DYOR. Just an opinion.
Over PAR, page-34
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.010(5.00%) |
Mkt cap ! $73.48M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 23.5¢ | 20.0¢ | $1.067M | 4.986M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1519 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 59999 | 2 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |